The Four Pillars of Weight Loss
RheumNow
Dr. John Cush
Tweet
ACR 2026 RheumNow Day 3 Recap https://t.co/WcQI9qnzUT
Article
Pain, fatigue and poor sleep are common concerns for people living with RA. In women approaching or experiencing menopause, joint and muscle pain, mood changes and sleep difficulties are recognised menopause-associated symptoms. A study from Mayo Clinic at this year’s ACR Convergence examines
Antoni Chan MD (Prof)
Tweet
ACR 2025 SLE guidelines on the management of haematological manifestations of the condition #SLE #ACR26 @RheumNow https://t.co/RmoALrntz3
Dr. John Cush
Tweet
RheumNow’s expanded coverage of the #ACR26 meeting is sponsored by Eli Lilly and Company.
All content is independently selected by RheumNow and its faculty.
Dr. John Cush
Tweet
RheumNow’s expanded coverage of #ACR26 Annual Meeting is sponsored by Beeline Medicines, Boehringer Ingelheim, Bristol Myers Squibb, and Tonix. All coverage content is independently selected by RheumNow and its faculty.
Dr. John Cush
Tweet
ACR 2026 – Day 1 Report
ACR Convergence was off to a big start with the year in review, posters and plenary sessions. Here are a few of our favorite presentations from today's Plenary I session at ACR Convergence. 2/5 plenary abstracts focused on weight loss, one on artificial https://t.co/d1u0nElhov
Mrinalini Dey
Tweet
CDAI remission does not describe every symptom. In a 787-patient RA study, those in remission still had meaningful pain interference (19%), fatigue (20%) and impaired function (23%). PROMIS scores show symptoms that composite score missed. #2874 @Rheumnow #ACR26
sheila
Tweet
Accdg to this study, milk composition - macronutrients - of pts with SARDs was comparable to controls.
Key takeaway? Counsel mothers w/ SARDs and advocate for breastfeeding.
@RheumNow #ACR26 Abs2458 https://t.co/2JclXSYRJi
Dr. John Cush
Tweet
RheumNow’s expanded coverage of #ACR26 annual meeting is sponsored by UCB.
All coverage content is independently selected by RheumNow and its faculty.
Akhil Sood MD, MS
Tweet
Abstract 2732: How do rheumatologists use and edit AI-scribe generated documentation?
- HPI use is more common: (76.4%) incl. ~ 50% w/ edits
- A&P use is less common: 77.1% non-use
- A&P use including edits rose over time
#ACR26 @rheumnow https://t.co/bzTbvdLbEm
Bella Mehta
Tweet
ACR26 Abstract #2243: Can AI see more in an ANA image than we do? Deep-learning models predicted several specific autoantibodies directly from HEp-2 immunofluorescence images, including anti-dsDNA with an AUC of 0.902. Exciting potential for laboratory triage @RheumNow
Bella Mehta
Tweet
New option for fibromyalgia. #ACR26 Abstract 2546: across 4 RCTs, bedtime sublingual cyclobenzaprine 5.6 mg reduced pain by ~1.8–1.9 points at 14 wks and was more consistent than 2.8 mg. Oral numbness occurred in 17–24%. Benefit is modest; discuss oral AEs. @RheumNow
Akhil Sood MD, MS
Tweet
What drives delays in lupus diagnosis?
Abstract 2748 found
• After 2010, time to diagnosis 4.7 years (mean)
• Older age, race (Am. indian/Alaska native), and specific sx. at onset (fatigue, pregnancy complications, heavy menstrual bleeding) linked to delay
#ACR26 @RheumNow
Mrinalini Dey
Tweet
A new RA target? Modified scores excluding TJC & patient global identified more patients with low inflammatory activity, with similar/lower radiographic progression than conventional remission. Useful where comorbidities may influence assessments #2808 #ACR26 @Rheumnow #ACRBest https://t.co/GZUOBc3mKn
Bella Mehta
Tweet
Reproductive health counseling in SLE: interviews with 30 Hispanic women and 26 Rheums found differences. Pts viewed it as ongoing life planning; physicians discussed it reactively with active disease or teratogenic meds.
Start early.
Ask goals. #ACR26 @rheumnow Abstract #1713
Bella Mehta
Tweet
A striking lupus treatment gap: 10K pts Medicaid-insured patients, only 60% with lupus nephritis and 41% with extrarenal SLE received HCQ, despite its foundational role. Guidelines cannot improve outcomes if patients cannot access therapy. @rheumnow #ACR26 Abstract #0286
Bella Mehta
Tweet
Can early SLE treatment change the disease trajectory? BE-EARLY evaluates belimumab within 2 years of diagnosis, before organ damage, using LLDAS, DORIS remission and damage prevention. Important idea, but the interim study is open-label. @rheumnow #ACR26 Abstract #1211 https://t.co/d9EkdT62Fp
Dr. John Cush
Tweet
RheumNow’s expanded coverage of the #ACR26 annual meeting is sponsored by Beeline Medicines, Boehringer Ingelheim, Bristol Myers Squibb, and Tonix. All coverage content is independently selected by RheumNow and its faculty.
Jiha Lee
Tweet
Can a structured program get PsA patients off prednisolone?
A 3-step model:
1. GC education for patients and physicians
1. Individualized 12wk taper
3. Feedback line for adherence problems
26/46 (56.5%) stopped GC by 3mo.
A#2303 @RheumNow #ACR26
Antoni Chan MD (Prof)
Tweet
EspAnde, Spain: an integrated primary care and rheumatology referral pathway in 328 patients. Key finding: axSpA diagnostic delay fell from 44 to 16 months, and referral wait from 4.0 to 0.4 months. @rheumnow #ACR26 Abstract#2540
sheila
Tweet
What’s new in the 2026 ACR Tx Guideline for #osteoarthritis ?
- strong recos for walking
- GLP-1RA for obese pts for wgt loss
- MTX gets conditional reco for inflammatory type of hand OA
- Chondroitin against knee, hip & hand OA
@RheumNow #ACR26 https://t.co/rFmJnmfVk9
sheila
Tweet
2026 Guidelines for treatment of #osteoarthritis
On GPS for recommending PT/OT:
These statements reflect how the appreciative role of PT and OT can help patients with social roles and improve their work environment
@RheumNow #ACR26 https://t.co/pY9aghE52a
Article
Steroids remain both the cornerstone and the Achilles' heel of PMR management. We have aspirations of briskly tapering our patients once they have had their honeymoon phase with prednisone. But when Ms. Jones calls you with a reported second PMR symptom relapse at a 6 milligram
Jiha Lee
Tweet
Pharmacology Update 2026
Some interesting developments in the pipelines...
@RheumNow #ACR26 https://t.co/ydBatbQfwg
Jiha Lee
Tweet
Vaccination key to preventing serious infection with b/tsDMARD use, especially in older adults and those with multimorbidity.
Updated 2026 EULAR guidelines for vaccination
@RheumNow #ACR26 https://t.co/EeWF8mHdgw
Therapeutic Updates
Watch our 'Four Pillars of Weight Loss' 8-part series as part of this month's The Obesity Imperative campaign.
Read Post
Podcasts
ACR 2026 RheumNow Day 1 Recap
Obesity & Inflammation: Understanding the Impact on Rheumatic Disease
RheumNow EULAR 2026 Rheumatology Round Up